EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Temperate phages increase antibiotic effectiveness in a Caenorhabditis elegans infection model

Rabia Fatima iD, Gayatri Nair, Jordan Mayol, Lesley T MacNeil, Alexander P Hynes iD

mBio · 10.09.2025 · 16 (9)

DOI: 10.1128/mbio.01621-25 ↗

Kurz gefasst

Fachartikel in der Zeitschrift mBio, erschienen am 10.09.2025. Verfasst von Rabia Fatima und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, Ontario, Canada. Hauptthemen laut MEDLINE: Caenorhabditis elegans, Anti-Bacterial Agents, Pseudomonas aeruginosa, Bacteriophages. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Sciences and Engineering Research Council of Canada, Farncombe Family.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The bactericidal nature of obligately lytic bacterial viruses (phages) is of increasing interest for the treatment of drug-resistant bacterial infections, often alongside antibiotics. By contrast, temperate phages are largely ignored due to their ability to lie dormant within the bacterial host. However, these phages often undergo a lytic cycle. Furthermore, in their dormant state, they switch to lytic replication in response to triggers, such as antibiotics, that stress the bacterial host. Recent reports of antibiotics synergizing with temperate phages in vitro , termed “temperate phage-antibiotic synergy” (tPAS), present a potentially scalable opportunity to make use of these abundant entities in therapy. Here, we employ Caenorhabditis elegans as a model to test the efficacy of temperate phages. In vivo , temperate phage Hali alone results in 60% dormancy in the bacterial survivors. However, the antibiotic ciprofloxacin can abolish dormancy of the phage—even in a ciprofloxacin-resistant Pseudomonas aeruginosa clinical strain. The phage Hali-ciprofloxacin pairing increased the lifespan of P. aeruginosa -infected worms to that of the uninfected control, at doses where neither the phage nor the antibiotic had any effect alone. Complete rescue was also observed in worms infected with a phage-carrying strain treated with the otherwise ineffective antibiotic, supporting that the phage—even in its dormant form—can greatly enhance antibiotic effectiveness. This illustrates potential “accidental” phage therapy when antibiotics are prescribed. As the first in vivo demonstration of tPAS, our work establishes C. elegans as a model for studying it, greatly expanding the therapeutic potential of temperate phages. IMPORTANCE Bacterial viruses (phages), which can go dormant in their host, are not considered suitable for phage therapy. Building on prior work showing antibiotics synergize with these phages by preventing dormancy, we test the ability of temperate phages—in combination with antibiotics—in an animal model of infection. Not only were the combinations extremely effective at doses that would do nothing alone, even when the bacterium was resistant to the antibiotics—but we also found that whether the dormant phage pre-existed (as it does in about 75% of bacteria) or not determined the success of antibiotic treatments, suggesting many antibiotic treatments are already a form of “accidental” phage therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Caenorhabditis elegansAnti-Bacterial AgentsPseudomonas aeruginosaBacteriophagesPhage TherapyPseudomonas InfectionsAnimalsDisease Models, AnimalCiprofloxacin

Stichwörter der Autor:innen

C. elegansbacteriophage therapyinductionlysogenyphage antibiotic synergytemperate phages

Substanzen

Anti-Bacterial AgentsCiprofloxacin

Autor:innen und Institutionen

  • Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, Ontario, Canada.
  • Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
  • Farncombe Family Digestive Health Research Institute, McMaster University, Hamilton, Ontario, Canada.
  • Michael G. DeGroote Institute for Infectious Disease Research, McMaster University, Hamilton, Ontario, Canada.

ORCID-Profile: Rabia Fatima, Alexander P Hynes

Förderung

  • Natural Sciences and Engineering Research Council of Canada
  • Farncombe Family

Zitieren

APA

Fatima, R., Nair, G., Mayol, J., MacNeil, L. T., & Hynes, A. P. (2025). Temperate phages increase antibiotic effectiveness in a Caenorhabditis elegans infection model. mBio, 16(9). https://doi.org/10.1128/mbio.01621-25

Vancouver

Fatima R, Nair G, Mayol J, MacNeil LT, Hynes AP. Temperate phages increase antibiotic effectiveness in a Caenorhabditis elegans infection model. mBio. 2025;16(9). doi:10.1128/mbio.01621-25

BibTeX
@article{Fatima2025,
  author = {Fatima, Rabia and Nair, Gayatri and Mayol, Jordan and MacNeil, Lesley T and Hynes, Alexander P},
  title = {Temperate phages increase antibiotic effectiveness in a Caenorhabditis elegans infection model},
  journal = {mBio},
  year = {2025},
  volume = {16},
  number = {9},
  doi = {10.1128/mbio.01621-25}
}
Kostenlos starten →